Lactoferrin as potential preventative and treatment for COVID-19

Raymond Chang, Wei-Zen Sun 03 Ago 2020
605 volte

The novel coronavirus 2019 (COVID-19) pandemic is rapidly advancing across the globe despite drastic public and personal health measures. Antivirals and nutritional supplements have been proposed as potentially useful against SARS-CoV-2 (virus that causes COVID-19), but few have been clinically established.

Lactoferrin (Lf) is a naturally occurring and non-toxic glycoprotein that is orally available as a nutritional supplement and has established in vitro anti-viral efficacy against a wide range of virus including SARS-CoV, a closely related corona virus to SARS-CoV-2 (virus that causes COVID-19). Furthermore, Lf possesses unique immunomodulatory and anti-inflammatory effects that may be especially relevant to the pathophysiology of severe COVID-19 cases.

We review the underlying biological mechanisms of Lf as an antiviral and immune regulator, and propose its unique potential as a preventative and adjunct treatment for COVID-19. We hope that further research and development of Lf nutritional supplementation would establish its role for COVID-19.

 

Read more: https://www.sciencedirect.com/science/article/pii/S0924857920303010

 

Per maggiori approfondimenti : 

https://scienzaonline.com/medicina/item/2621-una-risposta-contro-il-covid-19-la-glicoproteina-lattoferrina,-una-componente-dell%E2%80%99immunit%C3%A0-innata.html

https://scienzaonline.com/scienceonline-news/item/2597-lactoferrin-as-protective-natural-barrier-of-respiratory-and-intestinal-mucosa-against-coronavirus-infection-and-inflammation.html

https://scienzaonline.com/medicina/item/2672-ricerca-dati-a-confronto-covid19-colpisce-anche-la-tiroide.html

https://scienzaonline.com/scienceonline-news/item/2661-immunoprotein-impairs-sars-cov-2.html

Vota questo articolo
(0 Voti)

Lascia un commento

Assicurati di aver digitato tutte le informazioni richieste, evidenziate da un asterisco (*). Non è consentito codice HTML.

 

Scienzaonline con sottotitolo Sciencenew  - Periodico
Autorizzazioni del Tribunale di Roma – diffusioni:
telematica quotidiana 229/2006 del 08/06/2006
mensile per mezzo stampa 293/2003 del 07/07/2003
Scienceonline, Autorizzazione del Tribunale di Roma 228/2006 del 29/05/06
Pubblicato a Roma – Via A. De Viti de Marco, 50 – Direttore Responsabile Guido Donati

Photo Gallery